Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 777 to 826 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.23\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.37\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1121\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5557.17\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9304.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10347.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.9\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11161\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.81\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6547.99\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1116\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5890.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6548.28\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4025.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4474.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
axonemal dynein light intermediate polypeptide 1 (inner dynein arm light chain, axonemal) (hp28). [source:swissprot;acc:o14645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6772.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7526.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5036.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5596.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11107\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7154.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11075\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7154.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11069\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear receptor co-repressor/hdac3 complex subunit tblr1 (tbl1- related protein 1). [source:swissprot;acc:q9bzk7]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1x protein (transducin-beta-like 1, x-linked). [source:swissprot;acc:o60907]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1y protein (transducin-beta-like 1, y-linked). [source:swissprot;acc:q9bq87]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6075.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6746.92\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1105\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6456.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7169.75\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6455.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7168.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11047\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6455.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7167.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11045\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6770.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7517.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11036\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4708.61\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5226.71\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11003\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s19. [source:swissprot;acc:p39019]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l31. [source:swissprot;acc:p12947]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 3. [source:swissprot;acc:q9unx4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4039.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4484.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
jm1 protein. [source:refseq;acc:nm\_014008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5794.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6427.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10923\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase delta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p30049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6000.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6655.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10917\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
812\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
target of myb protein 1. [source:swissprot;acc:o60784]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5640.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6255.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10904\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin-associated protein-interacting protein (duo protein). [source:swissprot;acc:o60229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5641.11\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6255.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.109\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
triple functional domain protein (ptprf interacting protein). [source:swissprot;acc:o75962]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5641.12\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
midasin (midas-containing protein). [source:swissprot;acc:q9nu22]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4483.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4971.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10897\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
target of myb1-like 2; target of myb1 (chicken) homolog-like 2. [source:refseq;acc:nm\_144678]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5641.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10895\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase (ec 4.1.1.17) (odc). [source:swissprot;acc:p11926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6811.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7547.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10808\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminoadipate-semialdehyde synthase; lysine-ketoglutarate reductase /saccharopine dehydrogenase; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase. [source:refseq;acc:nm\_005763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6807.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7543.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10804\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase antizyme inhibitor. [source:swissprot;acc:o14977]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6805.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7540.5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10801\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [source:swissprot;acc:q96a70]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6805.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7540.99\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trna isopentenylpyrophosphate transferase. [source:refseq;acc:nm\_017646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6257.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6932.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10786\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6311.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6989.33\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10738\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6311.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6989.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase gamma chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p36542]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5657.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6263.02\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10702\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase oligomycin sensitivity conferral protein, mitochondrial precursor (ec 3.6.3.14) (oscp). [source:swissprot;acc:p48047]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exportin 1; exportin-1 (required for chromosome region maintenance); exportin 1 (crm1, yeast, homolog); crm1, yeast, homolog. [source:refseq;acc:nm\_003400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5195.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5750.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10678\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/